Researchers analyzed 2013-16 data on more than 32,000 adults from the Population Assessment of Tobacco and Health, a longitudinal study on tobacco use.
In 2013, none of the study participants showed symptoms of lung disease. However, e-cigarette users were 30 percent more likely to have a chronic lung condition — like asthma or emphysema — than nonsmokers by 2016.
“E-cigarette use predicted the development of lung disease over a very short period of time. It only took three years,” study author Stanton Glantz, PhD, a researcher at the University of California, San Francisco’s Center for Tobacco Control Research and Education, told NBC News.
The publication noted this is the first longitudinal study assessing the long-term effects of e-cigarettes.
To view the full study, click here.
More articles on population health:
How a ‘Grey’s Anatomy’ episode boosted sexual assault awareness
Social isolation and loneliness are America’s next public health issue
CDC: White adults had highest e-cigarette use in 2014, 2018
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
